STOCKHOLM, Nov. 18, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer’s Disease (CTAD) conference, being held in San Diego December 1-4. Presentations will…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
